Devices descending from K101424
4 later devices reach Pharmacaribe Inhaled Saline Solutions through their predicates, nearest generation first.
| Generation | Number | Device | Applicant | Decided | Own descendants | Recalls |
|---|---|---|---|---|---|---|
| +1 | K232523 | Sodium Chloride Inhalation Solution, USP 0.9%, 3% & 7% | Mankind Pharma Limited | 2024 | 0 | — |
| +1 | K210126 | Sodium Chloride Inhalation Solutions, 3%, 3.5%, 7% and 10% | The Ritedose Corporation | 2021 | 0 | — |
| +1 | K130091 | Pulmosal | Pharmacaribe | 2013 | 0 | 1 |
| +1 | K120051 | Sodium Chloride Inhalation Solution, 3%, 7%, and 10%, Usp-4ML | Nephron Pharmaceuticals Corp. | 2012 | 0 | 2 |